Scout Investments Inc. lowered its holdings in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 293,197 shares of the biopharmaceutical company’s stock after selling 4,600 shares during the period. Scout Investments Inc. owned about 0.20% […]
Eagle Asset Management Inc. lifted its stake in Insmed Incorporated (NASDAQ:INSM – Free Report) by 5.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 548,633 shares of the biopharmaceutical company’s stock after purchasing an additional 29,555 shares during the […]
Insmed (NASDAQ:INSM – Free Report) had its target price boosted by UBS Group from $46.00 to $58.00 in a research report released on Wednesday morning, Benzinga reports. UBS Group currently has a buy rating on the biopharmaceutical company’s stock. A number of other brokerages have also commented on INSM. The Goldman Sachs Group boosted their […]
Insmed (NASDAQ:INSM – Free Report) had its price objective upped by Truist Financial from $48.00 to $68.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the biopharmaceutical company’s stock. INSM has been the subject of several other research reports. Mizuho boosted their price target on shares of […]
Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 220,564 shares of Insmed stock in a transaction on Wednesday, May 29th. The stock was sold at an average price of $50.00, for a total transaction of $11,028,200.00. Following the completion of the transaction, the chief financial officer now owns 117,481 shares in the […]